Among human CDKs, CDK2 has been found to be significantly enriched in GBM tumors, and CDK2 inhibition reduced GBM cell proliferation and invasion and increased sensitivity to radiation both in vitro and in vivo [305, 306]. Here, CDK2 is linked to glioblastoma.